These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8090328)

  • 1. Angiotensin-converting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis.
    Pedersen EB
    Nephrol Dial Transplant; 1994; 9(5):482-92. PubMed ID: 8090328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin-converting enzyme inhibitor renography. Physiopathological, diagnostic and therapeutic aspects in renal artery stenosis].
    Pedersen EB
    Ugeskr Laeger; 1994 Feb; 156(7):948-54, 957. PubMed ID: 8009737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.
    Karanikas G; Becherer A; Wiesner K; Dudczak R; Kletter K
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):312-8. PubMed ID: 12002704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art review: captopril renography--pathophysiological considerations and clinical observations.
    Nally JV; Black HR
    Semin Nucl Med; 1992 Apr; 22(2):85-97. PubMed ID: 1589812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril scintigraphy in the study of arterial hypertension in pediatrics.
    Lagomarsino E; Orellana P; Muñoz J; Velásquez C; Cavagnaro F; Valdés F
    Pediatr Nephrol; 2004 Jan; 19(1):66-70. PubMed ID: 14648342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The radionuclide diagnosis of vasorenal hypertension using an angiotensin-converting enzyme inhibitor].
    Vozianov AF; Shcherbak AIu; Prishchepa PP; Zubko VI; Guts RV; Sabadash AS
    Lik Sprava; 1994; (9-12):64-8. PubMed ID: 7604589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal physiology of renal artery stenosis. Implications for captopril-stimulated renography.
    Nally JV
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):669S-674S. PubMed ID: 1777181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic renography and angiotensin converting enzyme inhibitor renography.
    Fine EJ
    Radiol Clin North Am; 2001 Sep; 39(5):979-95. PubMed ID: 11587065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renovascular hypertension. Radionuclide renography for detection and prediction of clinical response to revascularization].
    Muñoz A; Massardo T; González P
    Rev Med Chil; 1996 Sep; 124(9):1116-26. PubMed ID: 9197027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril renography for the detection of renovascular hypertension. A preliminary report.
    Nally JV; Gupta BK; Clarke HS; Higgins JT; Potvin WJ; Gross ML
    Cleve Clin J Med; 1988; 55(4):311-8. PubMed ID: 3136956
    [No Abstract]   [Full Text] [Related]  

  • 11. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty.
    Müller-Suur R; Tidgren B; Fehrm A; Lundberg HJ
    J Nucl Med; 2000 Jul; 41(7):1203-8. PubMed ID: 10914910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension.
    Johansson M; Jensen G; Aurell M; Friberg P; Herlitz H; Klingenstierna H; Volkmann R
    Kidney Int; 2000 Aug; 58(2):774-82. PubMed ID: 10916102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis.
    Geyskes GG; de Bruyn AJ
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):685S-689S. PubMed ID: 1837991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can exercise renography be an alternative to ACE inhibitor renography in hypertensive patients who are suspicious for renal artery stenosis?
    Mudun A; Falay O; Eryilmaz A; Karaman R; Cantez S
    Clin Nucl Med; 2004 Jan; 29(1):27-34. PubMed ID: 14688594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of captopril renography in renovascular hypertension.
    Oei HY; Geyskes GG; Mees EJ; Puylaert CB
    Contrib Nephrol; 1987; 56():95-103. PubMed ID: 3301206
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for renovascular disease with captopril-enhanced renography.
    McLean AG; Hilson AJ; Scoble JE; Maher ER; Thakrar DS; Moorhead JF; Sweny P
    Nephrol Dial Transplant; 1992; 7(3):211-5. PubMed ID: 1314991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver agreement on captopril renography for assessing renal vascular disease.
    Krijnen P; Oei HY; Claessens RA; Roos JC; van Jaarsveld BC; Habbema JD
    J Nucl Med; 2002 Mar; 43(3):330-7. PubMed ID: 11884492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renovascular hypertension: clinical concepts.
    Fenves AZ; Ram CV
    Minerva Med; 2006 Aug; 97(4):313-24. PubMed ID: 17008836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril renal scintigraphy in a patient with bilateral renal artery stenosis.
    Itoh K; Shinohara M; Togashi M; Koyanagi T
    J Nucl Med; 1989 Dec; 30(12):2042-5. PubMed ID: 2685193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney scintigraphy after ACE inhibition in the diagnosis of renovascular hypertension.
    Ghione S; Fommei E; Palombo C; Giaconi S; Mantovanelli A; Ragazzini A; Palla L
    Uremia Invest; 1985-1986; 9(2):211-5. PubMed ID: 3915923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.